Patents by Inventor Jerónimo Pachón Díaz

Jerónimo Pachón Díaz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SALICYLAMIDE DERIVATIVES AND RELATED METHODS OF MAKING
    Publication number: 20230140290
    Abstract: Certain embodiments describe antiviral compounds and related methods of using such compounds.
    Type: Application
    Filed: January 26, 2021
    Publication date: May 4, 2023
    Inventors: Jia ZHOU, Jimin XU, Javier SANCHEZ-CESPEDES, Judith BERASTEGUI-CABRERA, Maria Eugenia PACHON-IBANEZ, Jeronimo PACHON-DIAZ
  • VACCINE AGAINST ACINETOBACTER BAUMANNII BASED ON CELLULAR COMPONENTS DEFICIENT IN LIPOPOLYSACCHARIDE
    Publication number: 20220152184
    Abstract: The invention refers to a composition comprising inactivated cells deficient in LPS from the genus Acinetobacter and/or outer membrane vesicles form the same and their use for the manufacture of a medicament, preferably a vaccine, for the prevention of diseases produced by organisms of the genus Acinetobacter.
    Type: Application
    Filed: September 29, 2021
    Publication date: May 19, 2022
    Applicants: VAXDYN S.L., FUNDACIÓN PÚBLICA ANDALUZA PARA LA GESTIÓN DE LA INVESTIGACIÓN EN SALUD DE SEVILLA, SERVICIO ANDALUZ DE SALUD
    Inventors: Michael James McConnell, Meritxell García Quintanilla, Marina Pulido Toledano, María Pilar Pérez Romero, Jerónimo Pachón Díaz, Juan José Infante Viñolo
  • Vaccine against based on cellular components deficient in lipopolysaccharide
    Patent number: 11160856
    Abstract: The invention refers to a composition comprising inactivated cells deficient in LPS from the genus Acinetobacter and/or outer membrane vesicles form the same and their use for the manufacture of a medicament, preferably a vaccine, for the prevention of diseases produced by organisms of the genus Acinetobacter.
    Type: Grant
    Filed: January 24, 2018
    Date of Patent: November 2, 2021
    Assignees: Vaxdyn S.L., Fundación Pública Andaluza para la Gestión de la Investigación en Salud De Sevilla, Servicio Andaluz de Salud
    Inventors: Michael James McConnell, Meritxell García Quintanilla, Marina Pulido Toledano, María Pilar Pérez Romero, Jerónimo Pachón Díaz, Juan José Infante Viñolo
  • PIPERAZINE DERIVATIVES AS ANTIVIRAL AGENTS WITH INCREASED THERAPEUTIC ACTIVITY
    Publication number: 20190308956
    Abstract: The present invention provides 2-phenylpiperazine derivatives having a benzofuran-2-yl group which contributes to increase the antiviral activity as well as, for some substituents, the CC50, giving more active and less cytotoxic compounds. Although further optimization and characterization of their mechanisms of action will be required for these compounds, they represent strong hit candidates for the development of a new class of antiviral compounds.
    Type: Application
    Filed: February 23, 2017
    Publication date: October 10, 2019
    Inventors: Javier SÁNCHEZ CÉSPEDES, María Eugenia PACHÓN IBÁÑEZ, Jerónimo PACHÓN DÍAZ, Pablo MARTÍNEZ AGUADO, Tania CEBRERO CANGUEIRO, José Manuel VEGA PÉREZ, Fernando IGLESIAS GUERRA, Margarita VEGA HOLM, José Ignacio CANDELA LENA, Sarah MAZZOTTA
  • VACCINE AGAINST ACINETOBACTER BAUMANNII BASED ON CELLULAR COMPONENTS DEFICIENT IN LIPOPOLYSACCHARIDE
    Publication number: 20180256700
    Abstract: The invention refers to a composition comprising inactivated cells deficient in LPS from the genus Acinetobacter and/or outer membrane vesicles form the same and their use for the manufacture of a medicament, preferably a vaccine, for the prevention of diseases produced by organisms of the genus Acinetobacter.
    Type: Application
    Filed: January 24, 2018
    Publication date: September 13, 2018
    Applicants: VAXDYN S.L, FUNDACIÓN PÚBLICA ANDALUZA PARA LA GESTIÓN DE LA INVESTIGACIÓN EN SALUD DE SEVILLA, SERVICIO ANDALUZ DE SALUD
    Inventors: Michael James McConnell, Meritxell García Quintanilla, Marina Pulido Toledano, María Pilar Pérez Romero, Jerónimo Pachón Díaz, Juan José Infante Viñolo
  • VACCINE AGAINST ACINETOBACTER BAUMANNII BASED ON CELLULAR COMPONENTS DEFICIENT IN LIPOPOLYSACCHARIDE
    Publication number: 20170065700
    Abstract: The invention refers to a composition comprising inactivated cells deficient in LPS from the genus Acinetobacter and/or outer membrane vesicles form the same and their use for the manufacture of a medicament, preferably a vaccine, for the prevention of diseases produced by organisms of the genus Acinetobacter.
    Type: Application
    Filed: May 5, 2015
    Publication date: March 9, 2017
    Applicants: VAXDYN, S.L., FUNDACIÓN PÚBLICA ANDALUZA PARA LA GESTIÓN DE LA INVESTIGACIÓN EN SALUD DE SEVILLA, SERVICIO ANDALUZ DE SALUD
    Inventors: Michael James McConnell, Meritxell García Quintanilla, Marina Pulido Toledano, María Pilar Pérez Romero, Jerónimo Pachón Díaz, Juan José Infante Viñolo